病理是否是酒精和其他药物诱导的神经元损伤的相关因素?
Margrethe A Olesen1, Andrés Ancía1, Rodrigo A Quintanilla1
1Laboratory of Neurodegenerative Diseases, Instituto de Ciencias Biomédicas, Facultad de Ciencias de la Salud, Universidad Autónoma de Chile, Santiago, Chile.
Biochimica et biophysica acta. Molecular basis of disease
|September 24, 2025
概括
滥用物质,包括酒精和毒品,通过改变陶蛋白,导致类似神经退行性疾病的脑损伤. 了解这种病理是开发治疗认知衰退和成的关键.
科学领域:
- 神经科学是一个神经科学.
- 毒理学 毒理学 毒理学
- 成研究 研究成研究
背景情况:
- 滥用物质 (酒精,甲基胺,阿片类药物,大麻,可卡因) 导致全球健康问题.
- 药物滥用导致神经病理变化,认知能力下降和神经退行.
- 这些变化模仿神经系统疾病,如阿尔茨海默氏症和帕金森病.
研究的目的:
- 研究蛋白病理在药物滥用引起的神经退行症中的作用.
- 了解酒精和药物如何通过tau变化导致神经元损伤.
- 确定药物滥用和相关认知衰退的潜在治疗目标.
主要方法:
- 关于药物滥用,陶蛋白和神经退行症的当前文献的审查.
- 分析了将药物滥用与 fosforylation 和聚合联系在一起的机制.
- 药物诱导的病理与阿尔茨海默氏症和帕金森病病理的比较.
主要成果:
- 药物滥用会改变蛋白的酸化和切断,导致微管脱离.
- 这种tau病理破坏了轴突运输和突触可塑性.
- 异常的陶积累与认知衰退和因药物滥用的神经退行有关.
结论:
- 酒精和药物滥用诱导病理,导致神经退行和认知障碍.
- 准陶氏修饰机制可能为对抗药物滥用障碍提供新的策略.
- 进一步研究药物诱导的陶病症对于开发有效干预措施至关重要.
相关概念视频
CNS Depressants: Alcohol and Nicotine
1.0K
Ethanol, a clear colorless alcohol, has been consumed by humans for millennia, but its effects on the body are far from benign. At lower doses, it induces decreased inhibitions and loquaciousness, leading to its social appeal. However, it can cause severe consequences at higher doses, such as coma and respiratory depression, due to its zero-order elimination kinetics. Chronic ethanol abuse wreaks havoc on multiple organ systems, particularly the CNS and the liver. Abrupt cessation of ethanol...
1.0K
Alzheimer's Disease: Overview
1.6K
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
1.6K
Drugs Affecting Neurotransmitter Synthesis
2.1K
Drugs affecting neurotransmitter synthesis can impact the adrenergic neuron and the synthesis of neurotransmitters. For example, α-methyltyrosine and carbidopa target specific enzymes involved in catecholamine synthesis. α-methyltyrosine inhibits the enzyme tyrosine hydroxylase, which converts tyrosine into dopamine. By blocking this enzyme, α-methyltyrosine reduces dopamine production and other catecholamines. Carbidopa, on the other hand, inhibits the enzyme dopa decarboxylase,...
2.1K
Parkinson's Disease: Overview
1.8K
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
1.8K
Neural Regulation
43.1K
Digestion begins with a cephalic phase that prepares the digestive system to receive food. When our brain processes visual or olfactory information about food, it triggers impulses in the cranial nerves innervating the salivary glands and stomach to prepare for food.
43.1K


